A carregar...
Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants
BACKGROUND: Trivalent inactivated influenza vaccine (TIV) is not licensed for use in infants <6 months old, the group with the highest influenza hospitalization rates among children. METHODS: In this prospective, open-label study, 2 doses of TIV were administered to healthy infants aged 10–22 wee...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3773726/ https://ncbi.nlm.nih.gov/pubmed/18444800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/587643 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|